Page 1 of Clinical Trials for Kininogens, 49 Total Matches
- 1CompletedLast Updated: October 22, 2010Condition(s): Ischaemic Heart Diseases
- 2CompletedLast Updated: October 22, 2010Condition(s): Ischaemic Heart Diseases
- 3RecruitingLast Updated: July 14, 2011Condition(s): Coronary Arteriosclerosis
- 4RecruitingLast Updated: June 24, 2009Condition(s): Heart Transplantation
- 5Completed
- 6Enrolling by invitationLast Updated: March 24, 2009Condition(s): Coronary Artery Disease
- 7Enrolling by invitationLast Updated: June 24, 2009Condition(s): Heart Transplantation
- 8Active, not recruitingLast Updated: April 14, 2009Condition(s): Obesity
- 9RecruitingLast Updated: April 28, 2012Condition(s): Angiotensin-converting Enzyme (ACE) Inhibitor-associated Angioedema
- 10RecruitingLast Updated: July 24, 2009Condition(s): Angioneurotic Edema
- 11Not yet recruitingLast Updated: August 25, 2011Condition(s): Hypertension; Diabetes Type 2
- 12RecruitingLast Updated: August 11, 2009Condition(s): Obesity
- 13Completed
- 14RecruitingLast Updated: September 11, 2005Condition(s): Coronary Artery Disease
- 15CompletedLast Updated: March 3, 2008Condition(s): Atherosclerosis; Coronary Disease
- 16RecruitingLast Updated: August 25, 2011Condition(s): Thrombosis
- 17RecruitingLast Updated: September 9, 2005Condition(s): Healthy
- 18CompletedLast Updated: April 8, 2009Condition(s): Endothelial Dysfunction
- 19Recruiting
- 20RecruitingLast Updated: March 22, 2011Condition(s): Coronary Artery Disease; Angiotensin Converting Enzyme; Angiotensin Receptor Blockers; Cardiopulmonary Bypass; Fibrinolysis; Inflammation
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Kininogens
